Publications by authors named "Stacey T Long"

Claim this Profile
E
Enantiotropically-related polymorphs of {4-(4-chloro-3-fluorophenyl)-2-[4-(methyloxy)phenyl]-1,3-thiazol-5-yl} acetic acid: crystal structures and multinuclear solid-state NMR.
Frederick G Vogt, Lee M Katrincic, Stacey T Long, Ronald L Mueller, Robert A Carlton

J Pharm Sci· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acyclic, orally bioavailable ketone-based cathepsin K inhibitors.
David G Barrett, John G Catalano, David N Deaton, Stacey T Long, Robert B McFadyen

Bioorg Med Chem Lett· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors.
David G Barrett, John G Catalano, David N Deaton, Anne M Hassell, Stacey T Long

Bioorg Med Chem Lett· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?
Kim K Adkison, David G Barrett, David N Deaton, Robert T Gampe, Anne M Hassell, Stacey T Long

Bioorg Med Chem Lett· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P2-P3 conformationally constrained ketoamide-based inhibitors of cathepsin K.
David G Barrett, Virginia M Boncek, John G Catalano, David N Deaton, Anne M Hassell, Stacey T Long

Bioorg Med Chem Lett· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A structural screening approach to ketoamide-based inhibitors of cathepsin K.
David G Barrett, John G Catalano, David N Deaton, Stacey T Long, Robert B McFadyen

Bioorg Med Chem Lett· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and selective P2-P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1', P1, and/or P3 substitutions.
David G Barrett, John G Catalano, David N Deaton, Anne M Hassell, Stacey T Long

Bioorg Med Chem Lett· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orally bioavailable small molecule ketoamide-based inhibitors of cathepsin K.
David G Barrett, John G Catalano, David N Deaton, Stacey T Long, Larry R Miller

Bioorg Med Chem Lett· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of small molecule ketoamide-based inhibitors of cathepsin K.
John G Catalano, David N Deaton, Stacey T Long, Robert B McFadyen, Larry R Miller

Bioorg Med Chem Lett· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.
Francis X Tavares, Virginia Boncek, David N Deaton, Anne M Hassell, Stacey T Long

J Med Chem· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis